Fresenius Group Overview

The Health Care Group
Stories
Archive „Stories“
Investors
Contact

Fresenius SE & Co. KGaA

Investor Relations & Sustainability

+49 (0) 6172 608-2485
ir-fre@fresenius.com
Media
- News
- Social Media
- Calendar
- Contacts
- Media Center
Contact

Matthias Link

Senior Vice President Corporate Communications

T: +49 (0) 6172 608-2872
matthias.link@fresenius.com
Careers
Menu
Filter results
- Chapter
- Format
  - Website (0)
  - PDF (0)
Share
- Facebook
- Twitter
- LinkedIn
- Xing
- Google+
- E-Mail
Services
- Deutsch
- Print
- Contact
- RSS

In battle against the coronavirus

Fresenius is taking comprehensive measures to ensure healthcare is available for patients during the COVID-19 pandemic.
Read the story
An almost irreplaceable organ

The kidneys perform vital tasks in the body. A healthy lifestyle is important to prevent kidney failure.
Read the story
Growing up with parenteral nutrition

How two brave adventurers from Switzerland are exploring the world step-by-step.
Read the story
Living life to the fullest with dialysis

Alain Lempereur has been a dialysis patient for almost ten years at the NephroCare Maubeuge clinic in France. In this article, he tells us about his travels and numerous activities.
Read the story

News

Fresenius Medical Care partners with other dialysis providers to combat coronavirus pandemic in the U.S.

April 01, 2020Fresenius Medical Care

Fresenius successfully places bonds with a volume of 750 million euros

March 31, 2020Fresenius
Fresenius postpones 2020 Annual General Meeting

March 30, 2020Fresenius

Fresenius Medical Care postpones 2020 Annual General Meeting

March 30, 2020Fresenius Medical Care
Fresenius takes comprehensive measures to combat COVID 19 pandemic in Germany

March 27, 2020Fresenius Helios

Brief News
Fresenius Kabi resumes normal operations in China

With virtually all of Fresenius Kabi’s manufacturing staff in China returning to work post government-imposed COVID-19 quarantine restrictions, the company is ramping-up production back to normal levels. With a further stabilization of the situation, Fresenius Kabi also expects a gradual resumption of its sales force activities in China. Even though Fresenius Kabi faced challenges due to the COVID-19 pandemic and the quarantine measures, there was no major interruption of production. Thus, the company can supply the Chinese population with essential pharmaceuticals and medical devices.

March 24, 2020Fresenius Kabi
Fresenius Helios makes significant contribution to combating COVID-19 crisis in Spain

March 20, 2020Fresenius Helios

Brief News
Fresenius annual report 2019 online available

Our Annual Report 2019 is now available as a full-content PDF download and as an online short-version with the highlights. Annual Report (PDF) Online short-version

March 18, 2020Fresenius
Brief News
Fresenius subsidiary Curalie acquires Digitale Gesundheitsgruppe

Curalie, a subsidiary of Fresenius, has acquired Digitale Gesundheitsgruppe (DGG), one of its main competitors in Germany. Curalie and DGG both develop digital healthcare offerings to help patients with chronic illnesses. DGG targets family and specialist physicians with its “TeLiPro” telemedicine platform, while Curalie develops digital solutions for rehabilitation and aftercare. Combining the two companies creates the first provider that in all sectors of healthcare can digitally support patients during outpatient and inpatient care and through to aftercare.

March 18, 2020Fresenius

FDA clears Fresenius Medical Care’s Novalung for treatment of acute respiratory and cardiopulmonary failure

February 25, 2020Fresenius Medical Care
Potentialpark 2020 study shows Fresenius has Germany’s best online offering for job applicants

February 24, 2020Fresenius

Fresenius reports 16th consecutive record year

February 20, 2020Fresenius
Brief News
Fresenius Kabi and Vifor Pharma create joint venture in China for i.v. iron portfolio

Fresenius Kabi and Vifor Pharma have formed a joint venture in China to provide patients access to vital blood management treatment. It will combine Vifor Pharma’s leading intravenous drug portfolio for the treatment of iron deficiency with Fresenius Kabi’s strong and long-year presence in the market to benefit both patients and the healthcare system in China. The joint venture will focus on marketing, market access and medical affairs activities whereas Fresenius Kabi will be fully responsible for the commercialization of the intravenous iron portfolio. The joint company will be 55% owned by Vifor Pharma and 45% by Fresenius Kabi. Financial terms were not disclosed.

February 20, 2020Fresenius Kabi

Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth

February 19, 2020Fresenius Medical Care
Fresenius Helios acquires first hospital in Bogotá, continuing expansion in Colombia’s private hospital market

February 19, 2020Fresenius Helios

Fresenius Kabi inaugurates €30 million expansion of transfusion and apheresis disposables plant in Dominican Republic

January 24, 2020Fresenius Kabi
Brief News
Fresenius Kabi enters into joint venture to advance new cell and gene therapies

Fresenius Kabi, Bio-Techne and Wilson Wolf have formed a new joint venture to support researchers and biopharmaceutical companies in the field of cell and gene therapy. The joint venture is owned equally by the three partners and will focus on providing scalable manufacturing technologies and processes needed to develop and commercialize new cell and gene therapies. No financial terms were disclosed.

January 21, 2020Fresenius Kabi

Brief News
Fresenius Helios trains doctors in antibiotics management

Fresenius Helios has started training experts in antibiotics management to combat the growing threat from multi-resistant bacteria. In the coming years, more than 600 doctors will be trained at the company’s 86 hospitals in Germany on the correct way to handle antibiotics. These doctors will raise awareness of the problem among colleagues and be available for consultations with them. In addition, Fresenius Helios is introducing a system under which each hospital will report on its antibiotics usage.

January 16, 2020Fresenius Helios
Fresenius successfully places bonds with a volume of 750 million euros

January 07, 2020Fresenius

Fresenius Helios acquires leading private hospital in Colombia

December 23, 2019Fresenius Helios
Dr. Karl Schneider retiring from Supervisory Board of Fresenius Management SE and named honorary member

December 19, 2019Fresenius

Brief News
Fresenius Helios awards new innovation prize

Fresenius Helios has awarded its inaugural Helios-Pro-Inno Prize for outstanding innovation and projects in patient care and hospital management. Three different projects at Helios Wuppertal, Helios Berlin-Buch and Helios Bad Saarow hospitals in Germany were honored: A color and lighting concept that demonstrably improved the well-being of intensive care patients and even reduced their need for certain medications; the appointment of a “Feel Good Manager” for resolving employees’ problems in the workplace, and an antibiotics reporting system developed in response to the growing threat from multi-resistant bacteria. A jury of eight members, from different occupational groups, chose the Helios-Pro-Inno Prize winners from more than 70 entries.

December 10, 2019Fresenius Helios
Fresenius Medical Care places bonds with a volume of 1.75 billion euros

November 20, 2019Fresenius Medical Care

Brief News
Fresenius Vamed completes main university hospital building in Lübeck

After four years of construction Fresenius Vamed has completed the new main building at University Hospital Schleswig-Holstein (UKSH) in Lübeck. Following the opening in August of the new main building at the UKSH’s other location, in Kiel, the modernization of Germany’s second-largest university hospital is now largely complete. In addition to the new construction and the comprehensive renovation of the two university hospital locations, the project includes their technical management through 2044. With a total volume of €1.7 billion, the UKSH modernization is currently the biggest public-private partnership project in Europe’s healthcare sector.

November 12, 2019Fresenius Vamed
Brief News
Fresenius Vamed wins awards for spa and wellness facilities

VAMED Vitality World has been named the “World’s Best Thermal Spa & Medical Wellness Operator 2019” at the World Spa Awards. Four VAMED Vitality World facilities – Geinberg5 Private Spa Villas, St. Martins Therme & Lodge, Therme Laa Hotel & Spa and la pura women’s health resort – also won in their individual categories. VAMED Vitality World, part of Fresenius Vamed, operates a total of nine spa and health resorts in Austria.

November 05, 2019Fresenius Vamed

Fresenius Helios acquires medical diagnostics provider in Colombia

November 04, 2019Fresenius Helios
Brief News
Fresenius Medical Care launches connected health platform in North America

Fresenius Medical Care North America (FMCNA) has launched its new connected health platform called TheHub. The platform is comprised of three integrated applications - PatientHub, CareTeamHub and ProviderHub - that enable patients, care teams, and providers to better collaborate and monitor patient treatments. Research by FMCNA indicates that patients who actively use these connected health solutions have a 20 percent lower risk of hospitalization, higher transplantation rates, and stay on the modality longer.

November 04, 2019Fresenius Medical Care

Brief News
Fresenius Medical Care North America achieves strongest quality ratings to date

Fresenius Medical Care North America continues to improve clinical quality as measured by the U.S. government’s Five-Star Rating System. More than 94 percent of the company’s dialysis centers were rated three stars and above for clinical quality, with a total of 762 centers achieving the highest five star rating, up from 658 last year. The Centers for Medicare and Medicaid Services (CMS) assigns one to five stars to each dialysis center annually based on a series of measurements around clinical performance and patient outcomes.

November 01, 2019Fresenius Medical Care
Fresenius confirms guidance after solid third quarter

October 29, 2019Fresenius

Fresenius Medical Care again delivers strong organic growth in the third quarter

October 29, 2019Fresenius Medical Care

Disclaimer All news

NEXT EVENT

May 06, 2020 | Bad Homburg, Germany

Conference Call Q1 2020, Fresenius

Live Webcast

Import (ICS)

NEXT EVENT

Library

All Downloads

Follow us

The Health Care Group

Contact us

Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-0
pr-fre@fresenius.com

Contacts

Visit us